In the largest venture financing round this week, Varda Space Industries closed a $251 million financing round to help fund ...

Pharmaceutical launch plans are often thoroughly researched, carefully costed, and internally aligned. The problem is that ...

Frontiers Health 2026, strengthening a long-standing collaboration dedicated to advancing conversations around innovation in ...

Novartis has added a T-cell engager (TCE) developed by China's Abogen Biosciences for autoimmune disorders in a deal that ...

The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose ...

Bayer has looked internally for a new chief medical officer, appointing Dr Christoph Koenen to the position in addition to ...

Sanofi's long-running R&D alliance with Regeneron has gone up a gear with a partnership – worth up to $8 billion – that spans ...

The Global Benchmark for Efficient Drug Pricing (GLOBE) model aims to introduce the Trump administration's Most Favoured ...

Eli Lilly's bid to dominate the next generation of weight-loss therapies has been strengthened by data on a new combination ...

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial ...

AbbVie's long-acting anti-IL-13 antibody zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – ...

Patients in England and Wales with rare disease familial chylomicronaemia syndrome (FCS) will soon have a new treatment ...